CLPT - Clearpoint Neuro Inc
Clearpoint Neuro Inc Logo

CLPT - Clearpoint Neuro Inc

https://www.clearpointneuro.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
As of 2025-09-10 (Snapshot)

ClearPoint Neuro, Inc. is a medical device company primarily in the United States. The company is headquartered in Irvine, California.

52W High
$19.22
52W Low
$9.76

MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.89
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-7.07
EV/Revenue (<3 favorable)
9.17
P/S (TTM) (<3 favorable)
9.35
P/B (<3 favorable)
15.91
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
8.19%
Institutions (25–75% balanced)
38.99%
Shares Outstanding
28,427,400
Float
25,974,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
33,593,000
Gross Profit (TTM)
20,297,000
EPS (TTM)
-0.80
Profit Margin (>10% good)
-0.66%
Operating Margin (TTM) (higher better)
-0.62%
ROE (TTM) (>15% strong)
-0.86%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
0.17
Momentum
Bearish momentum
Value
-0.0546
Previous
-0.0227
Trend
Falling
Signal Cross
No cross

As of
Sep. 12, 2025